C. Soussy

发表

Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.

C. Brun-Buisson, J. Carlet, J. Lucet, 2010, Archives of internal medicine.

Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.

J. Duval, R. Leclercq, C. Soussy, 1992, The Journal of antimicrobial chemotherapy.

BLOOD NEUTROPHIL BACTERICIDAL ACTIVITY AGAINST METHICILLIN-RESISTANT AND METHICILLIN-SENSITIVE STAPHYLOCOCCUS AUREUS DURING CARDIAC SURGERY

L. Touqui, C. Delclaux, D. Loisance, 2005, Shock.

Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria.

P. Courvalin, C. Soussy, J. Sirot, 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR.

C. Soussy, D. Lamarque, J. Delchier, 1998, FEMS microbiology letters.

Quinolone resistance mutations in the gyrA gene of clinical isolates of Salmonella.

C. Soussy, J. Tankovic, S. Ouabdesselam, 1996, Microbial Drug Resistance.

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.

A. MacGowan, M. Steinbakk, A. Rodloff, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016

P. Woerther, C. Soussy, J. Decousser, 2018, Antimicrobial Resistance & Infection Control.

Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.

F. Mégraud, J. Nectoux, V. Cattoir, 2007, International journal of antimicrobial agents.

What technique should be used for routine detection and quantification of HBV DNA in clinical samples?

J. Pawlotsky, D. Dhumeaux, C. Soussy, 1997, Journal of virological methods.

Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens

P. Legrand, V. Cattoir, C. Soussy, 2006, Journal of Clinical Microbiology.

Single and Double Mutations in gyrA but Not in gyrB Are Associated with Low- and High-Level Fluoroquinolone Resistance in Helicobacter pylori

C. Soussy, J. Petit, C. Lascols, 2003, Antimicrobial Agents and Chemotherapy.

postinsult immune paralysis Decreased exhaled nitric oxide as a marker of

M. Riquet, C. Delclaux, S. Eddahibi, 2015 .

Decreased exhaled nitric oxide as a marker of postinsult immune paralysis.

C. Delclaux, S. Eddahibi, E. Marcos, 2004, Journal of applied physiology.

Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations

D. Hooper, C. Soussy, J. Tankovic, 1995, Antimicrobial agents and chemotherapy.

Fast and Accurate Quantitative Detection of Helicobacter pylori and Identification of Clarithromycin Resistance Mutations in H. pylori Isolates from Gastric Biopsy Specimens by Real-Time PCR

C. Copie-Bergman, C. Soussy, J. Petit, 2003, Journal of Clinical Microbiology.

Distribution and antimicrobial susceptibility of bacteria from adults with community-acquired pneumonia or complicated skin and soft tissue infections in France: the nationwide French PREMIUM study.

C. Soussy, J. Decousser, A. Emirian, 2015, Diagnostic microbiology and infectious disease.

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.

A. MacGowan, I. Odenholt, M. Steinbakk, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

BENEFICIAL EFFECT OF AN INHIBITOR OF LEUKOCYTE ELASTASE (EPI-hNE-4) IN PRESENCE OF REPEATED LUNG INJURIES

L. Brochard, A. Harf, C. Delclaux, 2004, Shock.

Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.

D. Dhumeaux, J. Miguet, C. Soussy, 1977, Gastroenterology.

In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

R. Leclercq, P. Legrand, C. Muller-Serieys, 2011, International journal of antimicrobial agents.

In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints

L. Armand-Lefèvre, R. Leclercq, P. Legrand, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.

I. Podglajen, R. Bonnet, J. Robert, 2007, International journal of antimicrobial agents.

Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV

D. Hooper, C. Soussy, S. Shah, 1997, Antimicrobial agents and chemotherapy.

Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus

D. Hooper, J. S. Wolfson, C. Soussy, 1993, Antimicrobial Agents and Chemotherapy.

Case of false-positive results of the urinary antigen test for Legionella pneumophila.

C. Brun-Buisson, P. Legrand, C. Soussy, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

a subunit of topoisomerase IV . coli is a mutant allele of the parE gene Quinolone resistance locus nfxD of Escherichia

D. Hooper, C. Soussy, S. Shah, 1996 .

Definition of the Clinical Antibacterial Spectrum of Activity.

C. Soussy, F. Goldstein, A. Thabaut, 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.

B. Campillo, J. Richardet, C. Soussy, 2006, The Journal of hospital infection.

Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats*

L. Brochard, A. Harf, C. Brun-Buisson, 2002, Critical care medicine.

European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.

C. Soussy, D. Brown, D. Felmingham, 1998, Diagnostic microbiology and infectious disease.

Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.

E. Cambau, A. Mérens, C. Soussy, 2008, The Journal of antimicrobial chemotherapy.

Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia.

R. Leclercq, P. Legrand, V. Cattoir, 2007, The Journal of antimicrobial chemotherapy.

A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France.

F. Mégraud, J. Duval, R. Cluzel, 1992, The Journal of antimicrobial chemotherapy.

Bacterial hypermutation: clinical implications.

F. Guillé, M. Bonnaure-Mallet, B. Kovács, 2011, Journal of medical microbiology.

The Pentapeptide Repeat Proteins MfpAMt and QnrB4 Exhibit Opposite Effects on DNA Gyrase Catalytic Reactions and on the Ternary Gyrase-DNA-Quinolone Complex

V. Jarlier, A. Aubry, S. Matrat, 2008, Journal of bacteriology.

Unexpected Occurrence of Plasmid-Mediated Quinolone Resistance Determinants in Environmental Aeromonas spp.

P. Nordmann, L. Poirel, V. Cattoir, 2008, Emerging infectious diseases.

[Resistance of nongroupable streptococci to beta-lactams. Detection by antibiogram and the activity of combinations of penicillin G and gentamicin].

R. Leclercq, C. Soussy, S. Besbes, 1988, Pathologie-biologie.

[Effectiveness and tolerance of piperacillin in 333 patients].

C. Soussy, Y. Mouton, C. Beuscart, 1986, Presse medicale.

EUCAST expert rules in antimicrobial susceptibility testing.

A P MacGowan, G Kahlmeter, P. Nordmann, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[Antibiogram Committee of the French Microbiology Society. Report 2000-2001].

G Carret, J Sirot, V. Jarlier, 2000, Pathologie-biologie.

Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates.

P. Nordmann, L. Poirel, V. Rotimi, 2007, The Journal of antimicrobial chemotherapy.

A Plasmid-Borne Shewanella algae Gene, qnrA3, and Its Possible Transfer In Vivo between Kluyvera ascorbata and Klebsiella pneumoniae

L. Gutmann, I. Podglajen, E. Cambau, 2008, Journal of bacteriology.

Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005.

L. Gutmann, V. Jarlier, R. Bonnet, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevalence of qnr genes in Salmonella in France.

F. Weill, P. Nordmann, L. Poirel, 2007, The Journal of antimicrobial chemotherapy.

In-vitro antibacterial activity of cefepime: a multicentre study.

J. Duval, R. Cluzel, P. Courvalin, 1993, The Journal of antimicrobial chemotherapy.

Group C streptococcal meningitis in adults.

C. Soussy, O. Patey, C. Buisson, 1990, Reviews of infectious diseases.

In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.

H. Chardon, A. Andremont, R. Leclercq, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods.

R. Leclercq, C. Muller-Serieys, J. Etienne, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Characterization of Mutations in therpoB Gene That Confer Rifampin Resistance inStaphylococcus aureus

P. Courvalin, C. Soussy, H. Aubry-Damon, 1998, Antimicrobial Agents and Chemotherapy.

[Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].

J. Duval, P. Courvalin, C. Soussy, 1986, Pathologie-biologie.

What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?

J. Pawlotsky, D. Dhumeaux, C. Hézode, 1998, Hepatology.

Specimens by Real-Time PCR Isolates from Gastric Biopsy pylori . H Clarithromycin Resistance Mutations in and Identification of Helicobacter pylori Fast and Accurate Quantitative Detection of

C. Copie-Bergman, C. Soussy, J. Petit, 2003 .

Low HCV replication levels in end-stage hepatitis C virus-related liver disease.

J. Pawlotsky, D. Dhumeaux, C. Duvoux, 1999, Journal of hepatology.

Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit.

F Lemaire, J. Meakins, F. Lemaire, 1989, Annals of internal medicine.

Definition and determination of in vitro antibiotic susceptibility breakpoints for Bacteria in France

R. Cluzel, P. Courvalin, C. Soussy, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation

L. Brochard, A. Harf, C. Brun-Buisson, 2003, Intensive Care Medicine.

Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C

J. Pawlotsky, F. Roudot-thoraval, D. Dhumeaux, 1998, Journal of medical virology.

Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France

C. Soussy, D. Sirot, F. Goldstein, 1992, Antimicrobial Agents and Chemotherapy.

P578 Updated qnr multiplex PCR–based technique: epidemiological survey of Qnr determinants in a collection of ESBL–producing enterobacterial isolates from Kuwait

P. Nordmann, L. Poirel, V. Rotimi, 2007 .

Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation.

C. Brun-Buisson, M. Thuong, C. Soussy, 2000, The Journal of antimicrobial chemotherapy.

Vibrio splendidus as the Source of Plasmid-Mediated QnrS-Like Quinolone Resistance Determinants

P. Nordmann, L. Poirel, D. Mazel, 2007, Antimicrobial Agents and Chemotherapy.

Roles of gyrA Mutations in Resistance of Clinical Isolates and In Vitro Mutants of Bacteroides fragilis to the New Fluoroquinolone Trovafloxacin

C. Soussy, L. Dubreuil, J. Tankovic, 2000, Antimicrobial Agents and Chemotherapy.

Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France.

F. Vandenesch, J. Croix, H. Chardon, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Novel Ambler Class A β-Lactamase LAP-1 and Its Association with the Plasmid-Mediated Quinolone Resistance Determinant QnrS1

P. Nordmann, L. Poirel, V. Cattoir, 2006, Antimicrobial Agents and Chemotherapy.

[Management of urinary tract infections in women. Epidemiologic survey of 7916 women in general practice].

F. Haab, C. Soussy, B. Lobel, 2006, Presse medicale.

First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland.

E. Cambau, C. Soussy, C. Lascols, 2008, The Journal of antimicrobial chemotherapy.

Frequent Association between Alteration of therdxA Gene and Metronidazole Resistance in French and North African Isolates of Helicobacter pylori

A. Labigne, C. Soussy, D. Lamarque, 2000, Antimicrobial Agents and Chemotherapy.

Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR.

C. Soussy, D. Lamarque, J. Delchier, 1998, FEMS microbiology letters.

Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin.

C. Soussy, C. Lascols, A. Bryskier, 2001, The Journal of antimicrobial chemotherapy.

In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis.

C. Soussy, J. Tankovic, R. Bachoual, 1999, The Journal of antimicrobial chemotherapy.

Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients

G. Dhonneur, L. Brochard, A. Harf, 2002, Critical care medicine.

Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use.

C. Brun-Buisson, R. Leclercq, P. Legrand, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.

C. Soussy, C. Lascols, F. Mory, 2001, Microbial drug resistance.

Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance in Helicobacter pylori

F. Mégraud, Vera Allerheiligen, E. Cambau, 2009, Journal of Clinical Microbiology.

Routine use of real-time PCR for detection of Helicobacter pylori and of clarithromycin resistance mutations.

C. Soussy, L. Deforges, J. Delchier, 2007, Gastroenterologie clinique et biologique.

Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole–amoxicillin–clarithromycin therapy

C. Soussy, C. Lascols, D. Lamarque, 2001, Alimentary pharmacology & therapeutics.

P. Woerther, C. Soussy, J. Decousser, 2018, Antimicrobial Resistance & Infection Control.

In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.

E. Denamur, P. Legrand, V. Cattoir, 2006, The Journal of antimicrobial chemotherapy.

In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.

P. Courvalin, C. Soussy, M. Kitzis, 1999, Journal of Antimicrobial Chemotherapy.

Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.

C. Soussy, C. Lascols, D. Lamarque, 2001, Pathologie-biologie.

Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli.

C. Soussy, J. Tankovic, R. Bachoual, 1998, Microbial drug resistance.

Resistance toCefotaxime andSevenOther13-Lactams in MembersoftheFamily Enterobacteriaceae: a3-Year Survey inFrance

M. Reverdy, C. Soussy, D. Sirot, 1992 .

[In vitro activity of the pristinamycin against the isolated staphylococci in the french hospitals in 1999-2000].

R. Leclercq, C. Soussy, N. Moniot-Ville, 2003, Pathologie-biologie.

GB virus C (GBV‐C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: Effect of interferon alfa therapy

J. Pawlotsky, F. Roudot-thoraval, D. Dhumeaux, 1998, Journal of medical virology.

Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy.

D. Hooper, C. Soussy, N. Moreau, 1995, The Journal of antimicrobial chemotherapy.

A Plasmid-Borne Shewanella algae Gene, qnrA3, and Its Possible Transfer In Vivo between Kluyvera ascorbata and Klebsiella pneumoniae

L. Gutmann, I. Podglajen, E. Cambau, 2008, Journal of bacteriology.

Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.

C. Brun-Buisson, J. Carlet, J. Lucet, 2010, Archives of internal medicine.

GB virus C (GBV‐C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: Effect of interferon alfa therapy

J. Pawlotsky, F. Roudot-thoraval, D. Dhumeaux, 1998, Journal of medical virology.